DOI:
10.1055/s-00000115
Suchttherapie
LinksClose Window
References
Laffont CM, Gomeni R, Heidbreder C. et al.
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000,
a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of
Buprenorphine, for the treatment of Opioid Use Disorder.
J Clin Pharmacol 2016;
56: 806-815
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.